Prices delayed by at least 15 minutes | Print


Creo Medical Group PLC (CREO)

ORD GBP0.001
Sell: 33.5p|Buy: 35p|Change: 0.50 (-1.44%)

Open 

34.75p


Previous close 

34.75p


Trade high 

35p


Volume 

709,100


Year high 

50.00p


Year low 

22.72p


Dividend yield 

-


Market capitalisation 

£123.81 mn


P/E ratio 

-


ISIN 

GB00BZ1BLL44


This share can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Dividend reinvestment

Share price

Performance 27/03/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Creo Medical Group PLC- 2.11
FTSE AIM All Share+ 0.35
More...

Company profile

Creo Medical Group PLC is a medical device company engaged in providing services in the field of surgical endoscopy. The company has developed a platform called Croma which is an electrosurgical platform to deliver microwave and bipolar radiofrequency through a single accessory port. The reportable segment of the company is the research and development of electrosurgical medical devices relating to the field of surgical endoscopy.

Sector 

Healthcare


News

Recent trades

DateTimePriceQuantityValue (£)
28/03/202405:08:2134.2536,38912,463.23
28/03/202404:30:5734.37515,0005,156.25
28/03/202404:29:2934.45580199.81
28/03/202404:10:1534.529,50010,177.50
28/03/202404:03:0333.51236,61779,290.36

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.